YL-939, a Potent Ferroptosis Inhibitor, Acts by Targeting the PHB2/Ferritin/Iron Axis
Ferroptosis is a form of programmed cell death mediated by iron-dependent lipid peroxidation and was first proposed by Brent Stockwell and Scott J. Dixon in 2012. It differs genetically and…